Table of Content

1 Report prologue
2 Market Introduction
2.1 Definition
2.2 Scope of the Study
2.3 Assumptions & Limitations
2.3.1 Assumptions
2.3.2 Limitations
2.4 Market Structure
3 Research Methodology
3.1 Research Process
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
3.5 Forecast Model
4 Market Dynamics
4.1 Introduction
4.2 Drivers
4.2.1 Worldwide Rising Prevalence of Q fever Coupled with Increasing Q Fever Hospitalization Rates
4.2.2 Rising Worldwide Cattle, Sheep, and Goat Population
4.2.3 Growth in the Risk Factors of Q Fever
4.2.4 Globally Growing Geriatric Population
4.3 Restraints
4.3.1 High Cost of Diagnostic Tests
4.3.2 Lack of Awareness About Q Fever
4.4 Opportunity
4.4.1 Presence of Untapped Opportunities in the Asia-Pacific and African Regions
4.5 Market Trends
4.6 Macroeconomic Indicators
5 Market Factor Analysis
5.1 Porter’s Five Forces Model
5.1.1 Bargaining Power of Suppliers
5.1.2 Bargaining Power of Buyers
5.1.3 Threat of New Entrants
5.1.4 Threat of Substitutes
5.1.5 Rivalry
5.2 Supply Chain Analysis
5.2.1 R&D and Development
5.2.2 Manufacturing
5.2.3 Distribution & Sales
5.2.4 Post-Sales Monitoring
5.3 Investment Feasibility Analysis
5.4 Pricing Analysis
6 Global Q Fever Market, By Type
6.1 Overview
6.2 Acute
6.3 Chronic
7 Global Q Fever Market, By Diagnosis
7.1 Overview
7.2 Serology Tests
7.3 Others
8 Global Q Fever Market, By Treatment
8.1 Overview
8.2 Antibiotics
8.3 Surgery
9 Global Q Fever Market, By End-User
9.1 Overview
9.2 Patients
9.3 Hospitals
9.4 Others
10 Global Q Fever Market, By Region
10.1 Overview
10.2 Americas
10.2.1 North America
10.2.1.1 US
10.2.1.2 Canada
10.2.2 Latin America
10.3 Europe
10.3.1 Germany
10.3.2 France
10.3.3 UK
10.3.4 Italy
10.3.5 Spain
10.3.6 Rest of Europe
10.4 Asia-Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Australia
10.4.5 South Korea
10.4.6 Rest of Asia-Pacific
10.5 Middle East & Africa
10.5.1 UAE
10.5.2 Saudi Arabia
10.5.3 Oman
10.5.4 Kuwait
10.5.5 Qatar
10.5.6 Africa
10.5.7 Rest of Middle East & Africa
11 Company Profile
11.1 Merck KGaA
11.1.1 Company Overview
11.1.2 Financial Overview
11.1.3 Products/Services Offered
11.1.4 SWOT Analysis
11.1.5 Key Developments
11.1.6 Key Strategies
11.2 Teva Pharmaceutical Industries Ltd
11.2.1 Company Overview
11.2.2 Financial Overview
11.2.3 Products/Services Offered
11.2.4 Key Developments
11.2.5 SWOT Analysis
11.2.6 Key Strategies
11.3 Pfizer Inc.
11.3.1 Company Overview
11.3.2 Financial Overview
11.3.3 Products/Services Offered
11.3.4 SWOT Analysis
11.3.5 Key Developments
11.3.6 Key Strategies
11.4 Basilea Pharmaceutica Ltd
11.4.1 Company Overview
11.4.2 Financial Overview
11.4.3 Products/Services Offered
11.4.4 Key Developments
11.4.5 SWOT Analysis
11.4.6 Key Strategies
11.5 Sanofi S. A.
11.5.1 Company Overview
11.5.2 Financial Overview
11.5.3 Products/Services Offered
11.5.4 SWOT Analysis
11.5.5 Key Developments
11.5.6 Key strategies
11.6 Melinta Therapeutics, Inc.
11.6.1 Company Overview
11.6.2 Financial Overview
11.6.3 Products/Services Offered
11.6.4 Key Developments
11.6.5 SWOT Analysis
11.6.6 Key Strategies
11.7 Bayer AG
11.7.1 Company Overview
11.7.2 Financial Overview
11.7.3 Products/Services Offered
11.7.4 SWOT Analysis
11.7.5 Key Developments
11.7.6 Key Strategies
11.8 Johnson & Johnson Services, Inc.
11.8.1 Company Overview
11.8.2 Financial Overview
11.8.3 Products/Services Offered
11.8.4 SWOT Analysis
11.8.5 Key Developments
11.8.6 Key Strategies
11.9 Yashica Pharmaceuticals
11.9.1 Company Overview
11.9.2 Financial Overview
11.9.3 Products/Services Offered
11.9.4 Key Developments
11.9.5 SWOT Analysis
11.9.6 Key Strategies
11.1 AtoxBio
11.10.1 Company Overview
11.10.2 Financial Overview
11.10.3 Products/Services Offered
11.10.4 Key Developments
11.10.5 SWOT Analysis
11.10.6 Key Strategies
12 Appendix
12.1 Discussion Blue Print



List of Figures



FIGURE 1 GLOBAL Q FEVER MARKET: MARKET STRUCTURE
FIGURE 2 RESEARCH PROCESS
FIGURE 3 TOP-DOWN & BOTTOM-UP APPROACH
FIGURE 4 MARKET DYNAMICS: ANALYSIS OF THE GLOBAL Q FEVER MARKET
FIGURE 5 PORTER’S FIVE FORCES ANALYSIS: GLOBAL Q FEVER MARKET
FIGURE 6 SUPPLY CHAIN: GLOBAL Q FEVER MARKET
FIGURE 7 GLOBAL Q FEVER MARKET SHARE, BY TYPE, 2017 (%)
FIGURE 8 GLOBAL Q FEVER MARKET, BY TYPE, 2017 & 2023 (USD THOUSAND)
FIGURE 9 GLOBAL Q FEVER MARKET SHARE, BY DIAGNOSIS, 2017 (%)
FIGURE 10 GLOBAL Q FEVER MARKET, BY DIAGNOSIS, 2017 & 2023 (USD THOUSAND)
FIGURE 11 GLOBAL Q FEVER MARKET, BY TREATMENT, 2015–2023 (USD THOUSAND)
FIGURE 12 GLOBAL Q FEVER MARKET SHARE, BY TREATMENT, 2017 (%)
FIGURE 13 GLOBAL Q FEVER MARKET, BY TREATMENT, 2017 & 2023 (USD THOUSAND)
FIGURE 14 GLOBAL Q FEVER MARKET SHARE, BY END USER, 2017 (%)
FIGURE 15 GLOBAL Q FEVER MARKET, BY END USER, 2017 & 2023 (USD THOUSAND)
FIGURE 16 GLOBAL Q FEVER MARKET SHARE, BY REGION, 2017 (%)
FIGURE 17 AMERICAS: Q FEVER MARKET SHARE, BY REGION, 2017 (%)
FIGURE 18 NORTH AMERICA: Q FEVER MARKET SHARE, BY COUNTRY, 2017 (%)
FIGURE 19 EUROPE: Q FEVER MARKET SHARE, BY COUNTRY, 2017 (%)
FIGURE 20 ASIA-PACIFIC: Q FEVER MARKET SHARE, BY COUNTRY, 2017 (%)
FIGURE 21 MIDDLE EAST & AFRICA: Q FEVER MARKET SHARE, BY COUNTRY, 2017 (%)

 

List of Tables



TABLE 1 PRIMARY INTERVIEWS
TABLE 2 TREATMENT COST FOR THE Q FEVER
TABLE 3 GLOBAL Q FEVER MARKET, BY TYPE, 2015–2023 (USD THOUSAND)
TABLE 4 GLOBAL Q FEVER MARKET, FOR ACUTE BY REGION, 2015–2023 (USD THOUSAND)
TABLE 5 GLOBAL Q FEVER MARKET, FOR CHRONIC BY REGION, 2015–2023 (USD THOUSAND)
TABLE 6 GLOBAL Q FEVER MARKET, BY DIAGNOSIS, 2015–2023 (USD THOUSAND)
TABLE 7 GLOBAL Q FEVER MARKET, FOR SEROLOGY TESTS BY REGION, 2015–2023 (USD THOUSAND)
TABLE 8 GLOBAL Q FEVER MARKET, FOR OTHERS BY REGION, 2015–2023 (USD THOUSAND)
TABLE 9 GLOBAL Q FEVER MARKET, FOR ANTIBIOTICS BY REGION, 2015–2023 (USD THOUSAND)
TABLE 10 GLOBAL Q FEVER MARKET, FOR SURGERY BY REGION, 2015–2023 (USD THOUSAND)
TABLE 11 GLOBAL Q FEVER MARKET, BY END USER, 2015–2023 (USD THOUSAND)
TABLE 12 GLOBAL Q FEVER MARKET, FOR PATIENTS BY REGION, 2015–2023 (USD THOUSAND)
TABLE 13 GLOBAL Q FEVER MARKET, FOR HOSPITALS BY REGION, 2015–2023 (USD THOUSAND)
TABLE 14 GLOBAL Q FEVER MARKET, FOR OTHERS BY REGION, 2015–2023 (USD THOUSAND)
TABLE 15 GLOBAL Q FEVER MARKET, BY REGION, 2015–2023 (USD THOUSAND)
TABLE 16 AMERICAS: Q FEVER MARKET, BY TYPE, 2015–2023 (USD THOUSAND)
TABLE 17 AMERICAS: Q FEVER MARKET, BY DIAGNOSIS, 2015–2023 (USD THOUSAND)
TABLE 18 AMERICAS: Q FEVER MARKET, BY TREATMENT, 2015–2023 (USD THOUSAND)
TABLE 19 AMERICAS: Q FEVER MARKET, BY END USER, 2015–2023 (USD THOUSAND)
TABLE 20 NORTH AMERICA: Q FEVER MARKET, BY COUNTRY, 2015–2023 (USD THOUSAND)
TABLE 21 NORTH AMERICAS: Q FEVER MARKET, BY TYPE, 2015–2023 (USD THOUSAND)
TABLE 22 NORTH AMERICAS: Q FEVER MARKET, BY DIAGNOSIS, 2015–2023 (USD THOUSAND)
TABLE 23 NORTH AMERICAS: Q FEVER MARKET, BY TREATMENT, 2015–2023 (USD THOUSAND)
TABLE 24 NORTH AMERICAS: Q FEVER MARKET, BY END USER, 2015–2023 (USD THOUSAND)
TABLE 25 US: Q FEVER MARKET, BY TYPE, 2015–2023 (USD THOUSAND)
TABLE 26 US: Q FEVER MARKET, BY DIAGNOSIS, 2015–2023 (USD THOUSAND)
TABLE 27 US: Q FEVER MARKET, BY TREATMENT, 2015–2023 (USD THOUSAND)
TABLE 28 US: Q FEVER MARKET, BY END USER, 2015–2023 (USD THOUSAND)
TABLE 29 CANADA: Q FEVER MARKET, BY TYPE, 2015–2023 (USD THOUSAND)
TABLE 30 CANADA: Q FEVER MARKET, BY DIAGNOSIS, 2015–2023 (USD THOUSAND)
TABLE 31 CANADA: Q FEVER MARKET, BY TREATMENT, 2015–2023 (USD THOUSAND)
TABLE 32 CANADA: Q FEVER MARKET, BY END USER, 2015–2023 (USD THOUSAND)
TABLE 33 LATIN AMERICA: Q FEVER MARKET, BY TYPE, 2015–2023 (USD THOUSAND)
TABLE 34 LATIN AMERICA: Q FEVER MARKET, BY DIAGNOSIS, 2015–2023 (USD THOUSAND)
TABLE 35 LATIN AMERICA: Q FEVER MARKET, BY TREATMENT, 2015–2023 (USD THOUSAND)
TABLE 36 LATIN AMERICA: Q FEVER MARKET, BY END USER, 2015–2023 (USD THOUSAND)
TABLE 37 EUROPE: Q FEVER MARKET, BY COUNTRY, 2015–2023 (USD THOUSAND)
TABLE 38 EUROPE: Q FEVER MARKET, BY TYPE, 2015–2023 (USD THOUSAND)
TABLE 39 EUROPE: Q FEVER MARKET, BY DIAGNOSIS, 2015–2023 (USD THOUSAND)
TABLE 40 EUROPE: Q FEVER MARKET, BY TREATMENT, 2015–2023 (USD THOUSAND)
TABLE 41 EUROPE: Q FEVER MARKET, BY END USER, 2015–2023 (USD THOUSAND)
TABLE 42 GERMANY: Q FEVER MARKET, BY TYPE, 2015–2023 (USD THOUSAND)
TABLE 43 GERMANY: Q FEVER MARKET, BY DIAGNOSIS, 2015–2023 (USD THOUSAND)
TABLE 44 GERMANY: Q FEVER MARKET, BY TREATMENT, 2015–2023 (USD THOUSAND)
TABLE 45 GERMANY: Q FEVER MARKET, BY END USER, 2015–2023 (USD THOUSAND)
TABLE 46 FRANCE: Q FEVER MARKET, BY TYPE, 2015–2023 (USD THOUSAND)
TABLE 47 FRANCE: Q FEVER MARKET, BY DIAGNOSIS, 2015–2023 (USD THOUSAND)
TABLE 48 FRANCE: Q FEVER MARKET, BY TREATMENT, 2015–2023 (USD THOUSAND)
TABLE 49 FRANCE: Q FEVER MARKET, BY END USER, 2015–2023 (USD THOUSAND)
TABLE 50 UK: Q FEVER MARKET, BY TYPE, 2015–2023 (USD THOUSAND)
TABLE 51 UK: Q FEVER MARKET, BY DIAGNOSIS, 2015–2023 (USD THOUSAND)
TABLE 52 UK: Q FEVER MARKET, BY TREATMENT, 2015–2023 (USD THOUSAND)
TABLE 53 UK: Q FEVER MARKET, BY END USER, 2015–2023 (USD THOUSAND)
TABLE 54 ITALY: Q FEVER MARKET, BY TYPE, 2015–2023 (USD THOUSAND)
TABLE 55 ITALY: Q FEVER MARKET, BY DIAGNOSIS, 2015–2023 (USD THOUSAND)
TABLE 56 ITALY: Q FEVER MARKET, BY TREATMENT, 2015–2023 (USD THOUSAND)
TABLE 57 ITALY: Q FEVER MARKET, BY END USER, 2015–2023 (USD THOUSAND)
TABLE 58 SPAIN: Q FEVER MARKET, BY TYPE, 2015–2023 (USD THOUSAND)
TABLE 59 SPAIN: Q FEVER MARKET, BY DIAGNOSIS, 2015–2023 (USD THOUSAND)
TABLE 60 SPAIN: Q FEVER MARKET, BY TREATMENT, 2015–2023 (USD THOUSAND)
TABLE 61 SPAIN: Q FEVER MARKET, BY END USER, 2015–2023 (USD THOUSAND)
TABLE 62 REST OF EUROPE: Q FEVER MARKET, BY TYPE, 2015–2023 (USD THOUSAND)
TABLE 63 REST OF EUROPE: Q FEVER MARKET, BY DIAGNOSIS, 2015–2023 (USD THOUSAND)
TABLE 64 REST OF EUROPE: Q FEVER MARKET, BY TREATMENT, 2015–2023 (USD THOUSAND)
TABLE 65 REST OF EUROPE: Q FEVER MARKET, BY END USER, 2015–2023 (USD THOUSAND)
TABLE 66 ASIA-PACIFIC: Q FEVER MARKET, BY COUNTRY, 2015–2023 (USD THOUSAND)
TABLE 67 ASIA-PACIFIC: Q FEVER MARKET, BY TYPE, 2015–2023 (USD THOUSAND)
TABLE 68 ASIA-PACIFIC: Q FEVER MARKET, BY DIAGNOSIS, 2015–2023 (USD THOUSAND)
TABLE 69 ASIA-PACIFIC: Q FEVER MARKET, BY TREATMENT, 2015–2023 (USD THOUSAND)
TABLE 70 ASIA-PACIFIC: Q FEVER MARKET, BY END USER, 2015–2023 (USD THOUSAND)
TABLE 71 JAPAN: Q FEVER MARKET, BY TYPE, 2015–2023 (USD THOUSAND)
TABLE 72 JAPAN: Q FEVER MARKET, BY DIAGNOSIS, 2015–2023 (USD THOUSAND)
TABLE 73 JAPAN: Q FEVER MARKET, BY TREATMENT, 2015–2023 (USD THOUSAND)
TABLE 74 JAPAN: Q FEVER MARKET, BY END USER, 2015–2023 (USD THOUSAND)
TABLE 75 CHINA: Q FEVER MARKET, BY TYPE, 2015–2023 (USD THOUSAND)
TABLE 76 CHINA: Q FEVER MARKET, BY DIAGNOSIS, 2015–2023 (USD THOUSAND)
TABLE 77 CHINA: Q FEVER MARKET, BY TREATMENT, 2015–2023 (USD THOUSAND)
TABLE 78 CHINA: Q FEVER MARKET, BY END USER, 2015–2023 (USD THOUSAND)
TABLE 79 INDIA: Q FEVER MARKET, BY TYPE, 2015–2023 (USD THOUSAND)
TABLE 80 INDIA: Q FEVER MARKET, BY DIAGNOSIS, 2015–2023 (USD THOUSAND)
TABLE 81 INDIA: Q FEVER MARKET, BY TREATMENT, 2015–2023 (USD THOUSAND)
TABLE 82 INDIA: Q FEVER MARKET, BY END USER, 2015–2023 (USD THOUSAND)
TABLE 83 AUSTRALIA: Q FEVER MARKET, BY TYPE, 2015–2023 (USD THOUSAND)
TABLE 84 AUSTRALIA: Q FEVER MARKET, BY DIAGNOSIS, 2015–2023 (USD THOUSAND)
TABLE 85 AUSTRALIA: Q FEVER MARKET, BY TREATMENT, 2015–2023 (USD THOUSAND)
TABLE 86 AUSTRALIA: Q FEVER MARKET, BY END USER, 2015–2023 (USD THOUSAND)
TABLE 87 SOUTH KOREA: Q FEVER MARKET, BY TYPE, 2015–2023 (USD THOUSAND)
TABLE 88 SOUTH KOREA: Q FEVER MARKET, BY DIAGNOSIS, 2015–2023 (USD THOUSAND)
TABLE 89 SOUTH KOREA: Q FEVER MARKET, BY TREATMENT, 2015–2023 (USD THOUSAND)
TABLE 90 SOUTH KOREA: Q FEVER MARKET, BY END USER, 2015–2023 (USD THOUSAND)
TABLE 91 REST OF ASIA-PACIFIC: Q FEVER MARKET, BY TYPE, 2015–2023 (USD THOUSAND)
TABLE 92 REST OF ASIA-PACIFIC: Q FEVER MARKET, BY DIAGNOSIS, 2015–2023 (USD THOUSAND)
TABLE 93 REST OF ASIA-PACIFIC: Q FEVER MARKET, BY TREATMENT, 2015–2023 (USD THOUSAND)
TABLE 94 REST OF ASIA-PACIFIC: Q FEVER MARKET, BY END USER, 2015–2023 (USD THOUSAND)
TABLE 95 MIDDLE EAST & AFRICA: Q FEVER MARKET, BY COUNTRY, 2015–2023 (USD THOUSAND)
TABLE 96 MIDDLE EAST & AFRICA: Q FEVER MARKET, BY TYPE, 2015–2023 (USD THOUSAND)
TABLE 97 MIDDLE EAST & AFRICA: Q FEVER MARKET, BY DIAGNOSIS, 2015–2023 (USD THOUSAND)
TABLE 98 MIDDLE EAST & AFRICA: Q FEVER MARKET, BY TREATMENT, 2015–2023 (USD THOUSAND)
TABLE 99 MIDDLE EAST & AFRICA: Q FEVER MARKET, BY END USER, 2015–2023 (USD THOUSAND)
TABLE 100 UAE: Q FEVER MARKET, BY TYPE, 2015–2023 (USD THOUSAND)
TABLE 101 UAE: Q FEVER MARKET, BY DIAGNOSIS, 2015–2023 (USD THOUSAND)
TABLE 102 UAE: Q FEVER MARKET, BY TREATMENT, 2015–2023 (USD THOUSAND)
TABLE 103 UAE: Q FEVER MARKET, BY END USER, 2015–2023 (USD THOUSAND)
TABLE 104 SAUDI ARABIA: Q FEVER MARKET, BY TYPE, 2015–2023 (USD THOUSAND)
TABLE 105 SAUDI ARABIA: Q FEVER MARKET, BY DIAGNOSIS, 2015–2023 (USD THOUSAND)
TABLE 106 SAUDI ARABIA: Q FEVER MARKET, BY TREATMENT, 2015–2023 (USD THOUSAND)
TABLE 107 SAUDI ARABIA: Q FEVER MARKET, BY END USER, 2015–2023 (USD THOUSAND)
TABLE 108 OMAN: Q FEVER MARKET, BY TYPE, 2015–2023 (USD THOUSAND)
TABLE 109 OMAN: Q FEVER MARKET, BY DIAGNOSIS, 2015–2023 (USD THOUSAND)
TABLE 110 OMAN: Q FEVER MARKET, BY TREATMENT, 2015–2023 (USD THOUSAND)
TABLE 111 OMAN: Q FEVER MARKET, BY END USER, 2015–2023 (USD THOUSAND)
TABLE 112 KUWAIT: Q FEVER MARKET, BY TYPE, 2015–2023 (USD THOUSAND)
TABLE 113 KUWAIT: Q FEVER MARKET, BY DIAGNOSIS, 2015–2023 (USD THOUSAND)
TABLE 114 KUWAIT: Q FEVER MARKET, BY TREATMENT, 2015–2023 (USD THOUSAND)
TABLE 115 KUWAIT: Q FEVER MARKET, BY END USER, 2015–2023 (USD THOUSAND)
TABLE 116 QATAR: Q FEVER MARKET, BY TYPE, 2015–2023 (USD THOUSAND)
TABLE 117 QATAR: Q FEVER MARKET, BY DIAGNOSIS, 2015–2023 (USD THOUSAND)
TABLE 118 QATAR: Q FEVER MARKET, BY TREATMENT, 2015–2023 (USD THOUSAND)
TABLE 119 QATAR: Q FEVER MARKET, BY END USER, 2015–2023 (USD THOUSAND)
TABLE 120 AFRICA: Q FEVER MARKET, BY TYPE, 2015–2023 (USD THOUSAND)
TABLE 121 AFRICA: Q FEVER MARKET, BY DIAGNOSIS, 2015–2023 (USD THOUSAND)
TABLE 122 AFRICA: Q FEVER MARKET, BY TREATMENT, 2015–2023 (USD THOUSAND)
TABLE 123 AFRICA: Q FEVER MARKET, BY END USER, 2015–2023 (USD THOUSAND)
TABLE 124 REST OF MIDDLE EAST & AFRICA: Q FEVER MARKET, BY TYPE, 2015–2023 (USD THOUSAND)
TABLE 125 REST OF MIDDLE EAST & AFRICA: Q FEVER MARKET, BY DIAGNOSIS, 2015–2023 (USD THOUSAND)
TABLE 126 REST OF MIDDLE EAST & AFRICA: Q FEVER MARKET, BY TREATMENT, 2015–2023 (USD THOUSAND)
TABLE 127 REST OF MIDDLE EAST & AFRICA: Q FEVER MARKET, BY END USER, 2015–2023 (USD THOUSAND)